Novartis Extends Its Reach in Radiopharmaceuticals With $1B Mariana Oncology Acquisition
Mariana Oncology brings Novartis a lead radiopharmaceutical program in development for small cell lung cancer. The deal is the latest in a string of big pharma M&A moves in the red-hot radiopharmaceuticals space.
The Rising Stakes of Healthcare Data Privacy in 2024: The Need for Practical Guidance
Where we’ve been, where we’re going, and how healthcare organizations can protect themselves from privacy risks caused by the Meta pixel and other third-party trackers
How ACOs Can Harness AI’s Transformative Potential
Strategies for building the datasets needed for ACOs to take advantage of artificial intelligence, manage costs and improve outcomes for all
Pepper Bio’s ‘Google Maps for Drug Discovery’ Finds Way to Potential New Liver Cancer Drug
Pepper Bio has licensed rights to lerociclib, a molecule that G1 Therapeutics designed to offer dosing and safety advantages over approved therapies in the same drug class. EQRx previously held rights to the drug, but returned them after the company was acquired last year.
Healthcare Is a Frontier Not Even Walmart Could Conquer — And It’s Not Looking Great For Others Either
Walmart’s decision to shutter its healthcare division reflects just how difficult it is to achieve profitability in the primary care and telehealth markets. Experts think retailers simply aren’t prepared to handle the bevy of challenges that come along with delivering healthcare — but could this news also be a sign of the system being broken?